Malaria Infections and Infestations Unspecified malaria
Conditions
Interventions
20 clusters from 17 villages across Muheza district in the northeast of Tanzania were profiled based on the malaria point prevalence, malaria vector densities and level of insecticide resistance. A st
Sponsors
University of Helsinki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Traditional Tanzanian village house with at least a single window or outlet which can accommodate the 3D-WDS and at least a single sleeping space 2. House made for long-term residential purposes (at least for the duration of the study) 3. At least one child aged 6 months - 14 years sleeping inside the house 4. Consent to 4.1. Install 3D-WDS in the house (intervention clusters only) 4.2. Use insecticide-treated nets (both intervention and control clusters) for a period of 12 months after the installation 4.3. Malaria screening for at least one child of the household
Exclusion criteria
Exclusion criteria: 1. Community houses with fixed window panels, shutters, or well-constructed aluminium panels with glass windows 2. Houses without a sleeping space i.e., made for the purpose of cooking and dining or cattle shed 3. Buildings that are temporarily constructed or made with the purpose to serve as a community hall, recreational centre, mosque or church 4. Households with no children aged 6 months to 14 years 5. Children without informed consent 6. Children with health conditions that require frequent hospital or health centre visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malaria prevalence measured using a rapid diagnostic test and thick blood smear at baseline, 10, 20, 30, 40 and 50 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 11/09/2024: 1. Anemia prevalence determined by measuring hemoglobin level using the Hemocue device at baseline, 10, 20, 30, 40 and 50 weeks 2. Body temperature measured using an infrared thermometer at baseline, 10, 20, 30, 40 and 50 weeks 3. Bio-metrics (height, weight and MUAC) measured using a measuring tape and weight scale at baseline, 10, 20, 30, 40 and 50 weeks 4. Indoor mosquito density measured using CDC-light traps at baseline, 10, 20, 30, 40 and 50 weeks 5. Entomological inoculation rate measured using CDC-light traps and RT-PCR at baseline, 10, 20, 30, 40 and 50 weeks 6. Acceptability of intervention measured using focus group discussions and interviews starting from week 50 over 3 weeks Previous secondary outcome measures: 1. Anemia prevalence is determined by measuring hemoglobin level using the Hemocue device at baseline, 10, 20, 30, 40 and 50 weeks 2. Body temperature is measured using an infrared thermometer at baseline, 10, 20, 30, 40 and 50 weeks 3. Bio-metrics (height, weight and MUAC) are measured using a measuring tape and weight scale at baseline, 10, 20, 30, 40 and 50 weeks 4. Indoor mosquito density is measured using CDC-light traps at baseline, 10, 20, 30, 40 and 50 weeks 5. Acceptability of intervention is measured using focus group discussions and interviews starting from week 50 over 3 weeks | — |
Countries
Tanzania
Outcome results
None listed